Zhejiang Wecome Pharmaceutical Company Limited (300878.SZ)

CNY 18.41

(-1.13%)

Total Debt Summary of Zhejiang Wecome Pharmaceutical Company Limited

Zhejiang Wecome Pharmaceutical Company Limited's latest annual total debt in 2023 was 435.24 Million CNY , up 36.4% from previous year.
Zhejiang Wecome Pharmaceutical Company Limited's latest quarterly total debt in 2024 Q1 was 192.94 Million CNY , down -55.67% from previous quarter.
Zhejiang Wecome Pharmaceutical Company Limited reported annual total debt of 319.1 Million CNY in 2022, up 287.54% from previous year.
Zhejiang Wecome Pharmaceutical Company Limited reported annual total debt of 82.33 Million CNY in 2021, up 459.62% from previous year.
Zhejiang Wecome Pharmaceutical Company Limited reported quarterly total debt of 192.94 Million CNY for 2024 Q1, down -55.67% from previous quarter.
Zhejiang Wecome Pharmaceutical Company Limited reported quarterly total debt of 332 Million CNY for 2024 Q3, down -7.31% from previous quarter.

Annual Total Debt Chart of Zhejiang Wecome Pharmaceutical Company Limited (2023 - 2013)

Historical Annual Total Debt of Zhejiang Wecome Pharmaceutical Company Limited (2023 - 2013)

Year	Total Debt	Total Debt Growth
2023	435.24 Million CNY	36.4%
2022	319.1 Million CNY	287.54%
2021	82.33 Million CNY	459.62%
2020	14.71 Million CNY	-91.08%
2019	164.92 Million CNY	134.82%
2018	70.23 Million CNY	146.44%
2017	28.5 Million CNY	0.0%
2016	- CNY	0.0%
2015	- CNY	0.0%
2014	- CNY	-100.0%
2013	18 Million CNY	0.0%

Year	Total Debt	Total Debt Growth
2024 Q2	364.11 Million CNY	88.71%
2024 Q1	192.94 Million CNY	-55.67%
2024 Q3	332 Million CNY	-7.31%
2023 Q1	404.06 Million CNY	26.63%
2023 FY	435.24 Million CNY	36.4%
2023 Q4	435.24 Million CNY	0.92%
2023 Q2	385.58 Million CNY	-4.57%
2023 Q3	431.26 Million CNY	11.85%
2022 Q4	319.1 Million CNY	207.37%
2022 FY	319.1 Million CNY	287.54%
2022 Q3	103.81 Million CNY	-18.2%
2022 Q1	82.36 Million CNY	0.03%
2022 Q2	126.91 Million CNY	54.09%
2021 Q3	60.48 Million CNY	451.39%
2021 FY	82.33 Million CNY	459.62%
2021 Q4	82.33 Million CNY	36.14%
2021 Q2	10.96 Million CNY	-10.88%
2021 Q1	12.3 Million CNY	-16.35%
2020 FY	14.71 Million CNY	-91.08%
2020 Q4	14.71 Million CNY	-92.12%
2020 Q2	186.65 Million CNY	0.0%
2020 Q1	- CNY	-100.0%
2020 Q3	186.76 Million CNY	0.06%
2019 Q4	164.92 Million CNY	0.0%
2019 FY	164.92 Million CNY	134.82%
2019 Q1	- CNY	0.0%
2018 FY	70.23 Million CNY	146.44%
2017 FY	28.5 Million CNY	0.0%
2016 FY	- CNY	0.0%
2015 FY	- CNY	0.0%
2014 FY	- CNY	-100.0%
2013 FY	18 Million CNY	0.0%

Peer Total Debt Comparison of Zhejiang Wecome Pharmaceutical Company Limited

Name	Total Debt	Total Debt Difference
Lifecome Biochemistry Co.,Ltd.	962.72 Million CNY	54.79%
Chengdu Kanghua Biological Products Co., Ltd.	194.75 Million CNY	-123.483%
NanHua Bio-medicine Co., Ltd	44.27 Million CNY	-883.001%
Shandong Sito Bio-technology Co., Ltd.	791.58 Million CNY	45.016%
Porton Pharma Solutions Ltd.	2.2 Billion CNY	80.301%
Guangdong VTR Bio-Tech Co., Ltd.	128.24 Million CNY	-239.385%